Connect with us


Why Pfizer Stock Dropped Today – Motley Fool

Investors are still waiting on data from Pfizer’s ongoing clinical trial for its coronavirus vaccine candidate.



post featured image

What happened
Shares of pharma giant Pfizer(NYSE:PFE) fell by as much as 5.6% on Wednesday and closed the day’s trading session down by 5.3%. While the broader stock market is feeling the pressure of a new surge in COVID-19 cases worldwide, one would expect Pfizer, a leader in the COVID-19 vaccine race, to benefit from these developments. However, investors are getting impatient with Pfizer, which has yet to release any data from its ongoing late-stage clinical trial for its coronavirus vaccine…

Click here to view the original article.

Continue Reading

You might also like ...

post featured image
Here’s What’s Pushing Tesla Stock Toward $600 — and Beyond – Motley Fool
post featured image
Coronavirus: Second-hand car website becomes latest ‘unicorn’ – BBC News
post featured image
Bitcoin price, altcoins and the Dow set record highs as bulls run the market – Cointelegraph